| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.14 | 0.003 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |